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To quantify gait bradykinesia during daily activity in patients with Parkinsonʼs disease (PD),  we mea-
sured movement-induced accelerations over more than 24h in 50 patients with PD and 17 age-matched 
normal controls,  using a new device,  the portable gait rhythmogram.  Acceleration values induced by 
various movements,  averaged each 10 min,  exhibited a gamma distribution.  The mean value of the 
distribution curve was used as an index of the “amount of overall movement per 24h”.  Characteristic 
changes were observed in both the gait cycle and gait acceleration.  During hypokinesia,  the gait cycle 
became either faster or slower.  A number of patients with marked akinesia/bradykinesia showed a 
reduced and narrow range of gait acceleration,  i.e.,  a range of ﬂoor reaction forces.  The results 
suggest that assessment of the combination of changes in gait cycle and gait acceleration can quantita-
tively deﬁne the severity of gait bradykinesia.
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kinesia and bradykinesia are core symptoms of 
Parkinsonʼs disease (PD) and are caused by 
progressive loss of melanin-containing neurons in the 
substantia nigra,  locus coeruleus,  and other brain 
structures [1,  2].  Akinesia is deﬁned as poor move-
ment generation,  whereas bradykinesia represents 
slowness of executed movements [3-5].  For proper 
assessment of the response to dopamine replacement 
therapy,  it is desirable to measure patient movements 
in daily activities and to identify and quantify akine-
sia/bradykinesia related to these movements.  However,  
quantitative estimation of motor symptoms in daily life 
is diﬃcult.  In fact,  the available pathophysiological 
data have been obtained from experimentally designed 
tasks,  including tasks of tracking a moving index [5] 
or tasks related to reaction time [6].  For quantitative 
assessment of akinesia/bradykinesia in daily activities,  
we focused on parkinsonian gait disorders [7,  8],  
since gait movements are represented by a few simple 
parameters such as cycle (cadence: steps per minute),  
A
Acta Med.  Okayama,  2012
Vol.  66,  No.  1,  pp.  31ﾝ40
CopyrightⒸ 2012 by Okayama University Medical School.
Original Article http ://escholarship.lib.okayama-u.ac.jp/amo/
Received May 18, 2011 ; accepted October 3, 2011.
＊Corresponding author. Phone : ＋81ﾝ3ﾝ3342ﾝ6111; Fax : ＋81ﾝ3ﾝ5381ﾝ6653
E-mail : utsumi-h@tokyo-med.ac.jp (H. Utsumi)
stride and ﬂoor reaction forces [7-12].
　 We developed a new long-term monitoring device,  
the portable gait rhythmogram (PGR),  which mea-
sures acceleration induced by limb and trunk move-
ments and gaits in daily life [8].  The main features of 
the device are: 1) it is capable of long-term monitor-
ing (＞40h),  2) it is designed to allow identiﬁcation of 
rhythmical gait movements from the voluntary limb and 
trunk movements or artifacts.
　 In the present study,  2 aspects of daily activities 
were analyzed using the PGR.  First,  we calculated an 
index that reﬂects overall movements within 24h 
estimated from accelerations induced by various move-
ments executed during daily life.  The PGR is designed 
to interpret decreased acceleration as poverty or 
slowness of movements.  Second,  we ﬁltered out non-
gait related accelerations.  Using data of the gait cycle 
and acceleration,  we determined the characteristic 
changes in gait cycle and ﬂoor reaction forces.  By 
comparing these parameters,  we attempted to construct 
a new test that allows quantitative assessment of aki-
nesia/bradykinesia in the daily activities of PD 
patients.
Materials and Methods
　 Subjects. The study subjects were 50 patients 
with PD (mean age,  70.3±7.6 years,  mean±SD,  30 
men and 20 women,  Table 1).  They represented all 
patients admitted to Tokyo Medical University Hospital 
between June 2009 and March 2010 who could walk 
unaided and showed no peak-dose dyskinesia during 
their ʻonʼ time.  They included 8 patients with Hoehn 
and Yahr stage I,  14 with stage II,  and 28 with stage 
III.  The duration of illness was 4.5±3.6 years.  The 
clinical status was determined using the Uniﬁed 
Parkinsonʼs Disease Rating Scale (UPDRS) motor 
score ʻonʼ state [13].  We also studied 17 age- and 
height-matched normal controls (mean age,  64.7±4.5 
years,  8 men and 9 women).  Matching for age and 
height was based on the ﬁnding that gait cycle and 
ﬂoor reaction forces are inﬂuenced by these 2 param-
eters [7,  8,  18].
　 Informed consent was obtained from all subjects.  
All procedures were conducted in accordance with the 
guidelines of the Ethics Committee of our institution.  
Statistical analysis was performed using the studentʼs 
t-test.  A p value of ＜0.05 denoted the presence of a 
signiﬁcant diﬀerence.
　 Measurement of acceleration induced by vari-
ous movements during daily activities. The 
PGR is a small device (size,  8×6×2cm,  weight,  
80g) that three dimensionally measures (ax,  ay,  az) 
accelerations associated with voluntary limb and trunk 
movements and accelerations induced by step-in and 
kick-oﬀ during gait (Mitsubishi Chemical Group Science 
and Technology Research Center,  Inc.,  Tokyo,  Japan) 
[8].  The PGR is attached to the patientʼs waist,  and 
records the above signals at a sampling rate of 10ms.  
The data are automatically stored in a microSD card.  
When recording is completed,  the absolute value of 
acceleration vectors (a;a2＝ax2＋ay2＋az2) is calculated 
and graphically displayed on the PC.  A fully-charged 
PGR can achieve 40 consecutive hours of recording.  
All recordings in the present study were performed 
for more than 24h and data of 24h were analyzed.
　 Evaluation of “amount of overall movements 
per 24-h”. After continuous recording for more 
than 24hrs,  the accelerations induced by all move-
ments were averaged every 10min of recording,  and 
the data were displayed graphically (Fig.  1).  Based on 
the assumption that the curve ﬁts the gamma distribu-
tion,  the mean value of the distribution was calculated 
mathematically.  The gamma distribution is deﬁned as 
the following formula.
f(x)＝xk-1 e-x/θ/Г(k)θk for x＞0
　 The mean value was named the “amount of overall 
movements per 24-h”,  representing an index of akine-
sia/bradykinesia.
　 Quantitative analysis of gait disorders
　 1. Identiﬁcation of acceleration induced by gait 
movements. The acceleration vectors caused by 
stepping can be distinguished from those by other 
voluntary limb and trunk movements or by artifacts,  
based on the algorithm of pattern matching [8].  Since 
the acceleration wave induced by gait motion is similar 
in shape in each patient,  the correlation is tested 
mathematically between the concerned waves and 
template.  Using this method,  we identiﬁed all steps 
that were performed during the 24h in each individual.  
The peak-to-peak interval was automatically detected 
to calculate the duration of one gait cycle.  We also 
measured the amplitude of the gait acceleration.  
Based on these parameters,  we documented the char-
acteristics of the gait cycle and the ﬂoor reaction 
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Table 1　 Characteristics of patients classiﬁed according to gait disorder pattern
Patient
number
Age (yrs) Sex
Duration of
illness
(yrs)
Hoehn
Yahr
UPDRS III
UPDRS III
26-31
Amount of
overall
movements per
24-h
Oﬀ
step cycle 
(sec)
Regression
slope in gait
acceleration
　Mild gait disorder
1 54 M 3 III 23 5 0.78 1.13 0.68
2 73 F 0.5 I 11 3 0.60 1.15 1.25
3 73 M 2 III 27 9 0.57 1.11 0.70
4 68 F 4 III 24 8 0.57 1.12 0.81
5 83 M 4 I 12 6 0.54 1.23 0.93
6 68 M 4 III 30 9 0.53 1.09 0.76
7 67 F 4.5 II 19 7 0.53 1.14 1.31
8 72 M 2 II 31 5 0.46 1.11 0.69
9 76 M 4 II 16 1 0.46 1.24 1.24
10 56 F 3 III 18 8 0.46 1.16 1.31
11 72 M 3.5 III 29 8 0.45 1.17 1.03
12 73 F 10 I 10 2 0.44 1.15 0.94
13 74 F 2 II 35 7 0.43 1.17 1.06
14 67 M 3.5 I 30 7 0.42 1.16 1.32
15 78 F 10 III 23 4 0.38 1.10 0.90
16 82 F 5 III 17 3 0.35 1.10 1.18
17 74 M 4 III 12 5 0.31 1.11 1.21
18 79 M 2 III 43 12 0.28 1.14 1.18
19 80 M 10 III 46 9 0.22 1.20 0.84
　Moderate gait disorder
20 64 F 13 III 21 6 1.10 1.30 0.80
21 63 M 5 III 29 8 0.68 0.99 0.42
22 65 M 1.5 III 26 7 0.66 1.00 0.54
23 63 F 0.5 II 23 5 0.59 1.35 0.90
24 65 M 1.5 III 26 7 0.49 1.02 0.69
25 64 M 2 II 10 3 0.48 1.42 1.13
26 71 M 9 III 24 8 0.43 1.29 1.07
27 63 F 1 I 21 8 0.41 1.39 1.13
28 56 M 0.5 II 11 4 0.40 0.99 1.08
29 70 F 3 III 13 5 0.39 1.04 0.69
30 65 M 1.5 I 10 2 0.39 1.32 1.26
31 75 M 12 III 28 5 0.36 1.30 1.34
32 70 F 5 II 30 5 0.35 1.01 1.44
33 70 F 6 II 21 5 0.33 0.97 1.11
34 77 M 3 I 14 7 0.32 1.26 1.15
35 65 F 3 III 15 7 0.31 1.25 1.32
36 70 F 3 I 9 5 0.31 1.01 1.05
37 75 M 3 III 23 9 0.30 1.29 1.44
38 78 F 2 III 31 12 0.29 1.40 1.15
39 82 M 3 III 32 9 0.24 1.26 1.12
40 70 F 2 III 17 8 0.23 1.03 1.29
　Moderate gait disorder
41 78 M 9 II 11 1 0.52 1.24 2.47
42 80 M 9 III 21 7 0.36 1.12 1.76
43 65 M 2 III 13 6 0.35 1.11 1.54
44 59 M 4 II 15 5 0.31 1.20 1.65
　Severe gait disorder
45 63 M 6 II 16 5 0.43 1.39 2.35
46 72 F 3 II 13 8 0.39 1.06 1.73
47 52 F 5 III 6 4 0.36 1.04 1.91
48 77 M 18 III 36 12 0.35 1.30 1.49
49 79 M 3 II 29 6 0.26 1.03 1.95
50 79 M 4 III 34 9 0.24 1.29 1.70
Hoehn Yahr,  Hoehn and Yahr stage;  UPDRS,  Uniﬁed Parkinsonʼs Disease Rating Scale.  Mild gait disorder group: patients who walked 
with normal rhythm and force,  Moderate gait disorder group: patients who walked with slow or fast rhythm or with reduced forces,  Severe 
gait disorder group: patients walked with both abnormal rhythm and reduced force.  Patients were arranged according to the amount of 
overall movements per 24-h.
force by the following 2 methods.
　 2. Estimation of changes in gait cycle duration 
during hypokinesia. The duration of the gait cycle 
was plotted against all motion-induced accelerations 
averaged each 10min (Fig.  2).  Thus,  the graph shown 
in Fig.  2 describes the relationship between the gait 
cycle and the amount of overall movements.  Two possi-
bilities were considered for low physical activity: 1) 
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Fig. 1　 Probability distribution of the averaged acceleration per 10min,  obtained from continuous recording for more than 24h.  (A) The 
summed average for 17 normal subjects.  (B-D) Thin lines: distribution curve for 17 normal controls,  bold line: distribution curve for a PD 
patient.  Patient #8 in B,  Patient #31 in C,  and Patient #40 in D.  The mean values of the distribution for Patients #8 in B,  #34 in C,  and 
#40 in D were less than the intersubject mean-1SD of the normal controls.  (E) Quantity of movements in one day of patients with UPDRS 
1-15,  16-30, and ｧ30.  NC shows that of normal controls. ＊P＜0.05,  ＊＊P＜0.01.
the patients did not move voluntarily,  or 2) the patient 
could not move due to akinesia/bradykinesia.  
Therefore,  this graph allows approxi mate estimation of 
changes in the gait cycle during hypokinesia.  Data 
collected over a short walking period (less than 50 
steps) were excluded due to the large variance.
　 3. Estimation of ﬂoor reaction forces. Since 
gait acceleration correlates with the ﬂoor reaction 
forces,  we measured gait acceleration as an index of 
the ﬂoor reaction forces.  The gait-induced accelera-
tions and duration of gait cycles were averaged for 
each 10-min recording (Fig.  3).  The graph shown in 
Fig.  3 indicates that changes in the gait acceleration 
correlate with the gait cycle duration.  The averaged 
logarithmic values showed normal distribution and the 
slope of the regression line was calculated using prin-
cipal component analysis.
Results
　 Amount of overall movements per 24-h. We 
ﬁrst analyzed the accelerations induced by all volun-
tary movements (all motion-induced accelerations) from 
the 24-h data recorded by the PRG.  Fig.  1 shows the 
probability distribution of the 10-min averaged accel-
erations.  Fig.  1A provides the summed average obtained 
from 17 normal control subjects.  Compared with the 
distribution curve of normal controls,  that of each PD 
patient was shifted to the left,  indicating poverty of 
movement (Patient #8 in B,  Patient #31 in C,  
Patient #40 in D).  The mean value of the distribution 
curve,  termed the “amount of overall movements per 24-h”,  
was calculated with the assumption that the curve ﬁt-
ted gamma distribution.  The intersubject mean value 
of the amount of overall movements per 24-h was 0.69±
0.19m/sec2 in normal controls.  The amount of overall 
movements per 24-h was 0.46m/sec2 in Patient #8 (Fig.  
1B),  0.36m/sec2 in Patient #31 (Fig.  1C),  and 
0.23m/sec2 in Patient #40 (Fig.  1D).  When the 
amount of overall movements per 24-h was less than the 
intersubject mean-1SD in normal controls (0.50m/
sec2),  it was deﬁned as signiﬁcant change; 38 of 50 
patients showed a signiﬁcant decrease in activities.  In 
Fig.  1,  Patient #8 (Fig.  1B),  Patient #31 (Fig.  1C) 
and patient #40 (Fig.  1D) exhibited signiﬁcant 
decreases in movement activities.
　 The amount of overall movements per 24-h varied 
according to the severity of PD.  Patients were clas-
siﬁed into 3 groups based on the UPDRS-III: patients 
with scores of 1-15,  those with scores of 16-30,  and 
those with scores ｧ30.  The amount of overall move-
ments per 24-h was 0.40±0.09m/sec2 in patients with 
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Fig. 2　 Relationship between all motion-induced accelerations and gait cycle durations.  Motion-induced accelerations and gait cycles 
were averaged every 10min and plotted.  The averaged values represented all steps during the 24h.  The plot includes the data of 17 nor-
mal controls (small circles) and those of PD patients (large circles).  The mean of the gait cycle was calculated within a range of the lower 
10% of motion-induced accelerations (ｦ0.45m/sec2,  vertical dotted line).  (A) Example of ʻFast stepping during hypokinesiaʼ (Patient 
#49).  The gait cycle was fast while the averaged motion-induced acceleration was low.  (B) Example of ʻSlow stepping during hypokine-
siaʼ (Patient #45).  The gait cycle was slow while the averaged motion-induced acceleration was low.  (C) The gait cycle was normal while 
the averaged motion-induced acceleration was low (Patient #8).
scores of 1-15,  0.48±0.18m/sec2 in patients with 
scores of 16-30,  and 0.31±0.09m/sec2 in patients 
with scores ｧ30 (Fig.  1E).  The amount of overall 
movements per 24-h for patients with scores ｧ30 was 
signiﬁcantly lower than that of patients with scores of 
1-15 (p＜0.05) and that of patients with scores of 
16-30 (p＜0.01).
　 Gait cycle during hypokinesia. Next,  we 
examined the relationship between activities and gait 
cycle.  All motion-induced accelerations and gait cycle 
duration were averaged each 10min and plotted (Fig.  
2).  The averaged values obtained from all steps 
achieved per 24h were plotted.  The results of 17 
normal controls were also plotted (small circles,  Figs.  
2A,  B and C).  In the normal controls,  the gait cycle 
duration did not change signiﬁcantly with the degree 
of physical activities.  On the other hand,  several 
patients (large circles in Figs.  2A and B) showed 
characteristic changes in the gait cycle during the time 
when all motion-induced accelerations were reduced,  
presumably during hypokinesia.
　 To estimate these changes quantitatively,  the mean 
gait cycle was calculated within a range of the lower 
10ｵ of all motion-induced accelerations (within a 
range of 0.45m/sec2).  The intersubject gait cycle was 
1.16±0.08 sec in normal controls.  Some PD patients 
walked with a gait cycle duration exceeding the inter-
subject mean±1SD of the controls.  Two paradoxical 
changes were observed.  Twelve patients (Patients 
#21,  22,  24,  28,  29,  32,  33,  36,  40,  46,  47,  49) 
walked using a fast step cycle when all motion-induced 
accelerations were low (Fig.  2A,  Patient #49).  This 
type of gait was termed ʻFast stepping during hypokine-
siaʼ.  In contrast,  15 patients (Patients #20,  23,  25,  
26,  27,  30,  31,  34,  35,  37,  38,  39,  45,  48,  50) 
walked using a slower cycle (Fig.  2B,  Patient #45),  
termed ʻSlow stepping during hypokinesiaʼ.  The other 23 
patients walked with a normal step cycle while the 
activity decreased (Fig.  2C,  Patient #8).
　 Gait acceleration as an index of ﬂoor reac-
tion forces. Fig.  3 shows the relationship between 
gait acceleration and gait cycle.  Both parameters 
were recorded continuously for more than 24h,  and 
then the average value for each 10min was computed.  
Fig.  3A shows the results of a normal control,  and 
Figs.  3B-D show those of PD patients with the cor-
responding regression line (thick line).  The regression 
line,  obtained from the summed average of 17 normal 
controls,  is also shown (thin line).
　 In the control subjects,  walking with a slower cycle 
was associated with a decrease in acceleration.  The 
slope of the linear regression line in logarithm was 
1.20±0.29 in normal controls.  Several PD patients 
showed characteristic changes.  The amplitude of the 
gait acceleration decreased in some patients (Patient 
#24 in Fig.  3B,  Patient #32 in Fig.  3C,  and Patient 
#49 in Fig.  3D).  Furthermore,  the range of gait 
acceleration was narrow,  and thus the slope was 
steeper (Figs.  3C and D).  The slope of the regres-
sion line exceeding the intersubject mean＋1SD 
(1.49) of the controls was deﬁned as signiﬁcant devia-
tion,  which was observed in 10 patients (Patients 
#41,  42,  43,  44,  45,  46,  47,  48,  49,  50).  In Fig.  
3,  the slope of the regression line was 0.69 in Patient 
#24 (Fig.  3B),  1.44 in Patient #32 (Fig.  3C),  and 
1.95 in Patient #49 (Fig.  3D).  Thus,  patient 49 in 
Fig.  3D can be considered part of the signiﬁcant 
deviation group.
　 Combination analysis of gait parameters:  
rhythm and force. Fig.  4A shows the relation-
ship between the pathophysiological changes in gait 
cycle and the ﬂoor reaction forces.  In this graph,  the 
abscissa represents a decrease in the ﬂoor reaction 
forces,  while the ordinate represents gait cycle changes 
during hypokinesia.  The z axis represents the number 
of patients.  Patients were classiﬁed into three 
groups: the mild gait disorder group comprised patients 
with a normal gait cycle and ﬂoor reaction forces 
(open bars,  n＝19,  38ｵ),  the moderate gait disorder 
group comprised patients in whom one of the parame-
ters was abnormal (gray bars,  n＝25,  50ｵ),  and the 
severe gait disorder group comprised patients in whom 
both parameters were outside the normal range (solid 
bars,  n＝6,  12ｵ).  The Table shows the clinical 
proﬁles of the three groups of patients.  The UPDRS-
III values were 24.0±10.4,  19.8±7.3,  and 22.3±
12.3 for the mild, moderate and severe groups,  respec-
tively.  The respective UPDRS-III 26-31 values were 
6.2±2.8,  6.2±2.3,  and 7.3±2.9.  For UPDRS-III 
26-31,  the score tended to be higher in the severe 
group,  albeit statistically insigniﬁcant (Fig.  4B).
　 The amount of overall movements per 24-h was also 
compared among the groups.  The number of patients 
who showed signiﬁcant changes in the amount of overall 
movements per 24-h was 12/19 (63.1ｵ) of the patients 
from the mild group,  20/25 (80.0ｵ) of the moderate 
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group,  and 6/6 (100.0ｵ) of the severe group.  On the 
other hand,  the values of the amount of overall move-
ments per 24-h were 0.46±0.12m/sec2,  0.42±0.18m/
sec2 and 0.33±0.07m/sec2 for the mild, moderate,  and 
severe groups,  respectively (Fig.  4C).  There was a 
signiﬁcant diﬀerence between the mild and severe 
groups (p＜0.01) and between the moderate and severe 
groups (p＜0.05).
Discussion
　 Actigraphy has been used to monitor movements 
and daily activities [14].  Although the extent of 
poverty of movements (akinesia) can be roughly esti-
mated using this method,  the slow nature of the exe-
cuted movements (bradykinesia) cannot be estimated by 
actigraphy.  The present study was designed to quan-
tify the degree of akinesia/bradykinesia in the daily 
lives of PD patients.  Using the long-term monitoring 
system of PGR,  we calculated the amount of daily 
movements as an index of the poverty of movements,  
and diﬀerentiated the nature of gait bradykinesia by 
identifying changes in the gait cycle and gait accelera-
tion (i.e.,  the ﬂoor reaction force).
　 Quantitative index for akinesia/bradykine-
sia. Using the PGR,  we measured the amount of 
overall movement,  similar to the parameters measured 
by actigraphy [14].  In the present study,  we also 
calculated a quantitative index for intersubject com-
parisons.  The acceleration values averaged each 
10min showed a mathematical gamma distribution.  
Thus,  we calculated the mean value of the distribu-
tion,  i.e.,  the amount of overall movements per 24-h.  The 
mean value should decrease in the presence of both 
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Fig. 3　 Relationship between gait acceleration and gait cycle duration.  Both parameters were recorded continuously for more than 24h 
and averaged every 10min.  (A) Data of a representative normal control.  (B-D) Data of a representative PD patient (large circles) with the 
corresponding regression curve (bold line).  Patient #24 in B,  Patient #32 in C,  and Patient #49 in D.  Thin line: the regression line 
obtained from the summed average values of 17 normal controls (A,  B,  C,  and D).  The slope of the regression line of Patient 49 in D 
exceeded the intersubject mean+1SD of the normal controls.
akinesia and bradykinesia.  Advanced UPDRS-III 
values are associated with a signiﬁcant decrease in the 
amount of overall movements per 24-h,  as shown in Fig.  
1E.  The amount of overall movements per 24-h was sig-
niﬁcantly low in patients with UPDRS-III ｧ30,  
indicating prominent poverty of movement (akinesia) in 
these patients.  It appears that there was no signiﬁcant 
diﬀerence between the UPDRS 1-15 and 16-30 
groups,  since UPDRS-III assesses not only akinesia,  
but other motor symptoms such as resting tremor or 
diﬃculties in motor performance.
　 Assessment of the amount of overall movements per 
24-h should take into consideration 2 issues: 1) con-
tamination with involuntary movements and 2) inter-
day variability in activity.  Involuntary movements 
should result in overestimation of accelerations.  
Resting tremor,  occurring periodically at 5-6 Hz,  was 
easily excluded using our analysis algorithm.  However,  
dyskinesia is diﬃcult to identify since it occurs 
irregularly and in a variety of forms.  Severe distur-
bances of the gait parameters,  associated with a high 
amount of overall movements per 24-h,  could reﬂect 
dyskinesia.  On the other hand,  diﬀerences in daily 
activities could also inﬂuence the movement-related 
accelerations.  Strenuous physical activity,  such as 
exercising or doing housekeeping chores,  should 
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Fig. 4　 (A) Relationship between changes in the gait cycle and acceleration.  The z axis represents the number of patients.  When both 
parameters were normal (open bars),  the patients were considered to have mild gait disorder.  When each parameter was abnormal (gray 
bars),  the patients were considered to have moderate gait disorder.  When both parameters were beyond the normal range (solid bars),  the 
patients were considered to have severe gait disorder.  (B) The mean UPDRS-III 26-31 value of the mild,  moderate and severe gait disor-
der groups.  (C) The amount of overall movements per 24 -h for each group.  ＊p＜0.05,  ＊＊p＜0.01.
increase acceleration.  Thus,  during monitoring with 
the PGR,  patients should be advised to engage only in 
their usual and routine daily activities,  and to refrain 
from any unusual activities.  Practically,  these 2 
problems cannot be avoided when measuring accelera-
tion and,  accordingly,  patients should be advised to 
use a diary to record daily activity,  which could be 
used during data analysis.
　 Changes in gait cycle during hypokinesia.
To explore changes in the gait cycle during hypokine-
sia,  we examined the relationship between the gait 
cycle and all motion-induced acceleration.  Both param-
eters were averaged each 10min.  Reductions in all 
motion-induced acceleration could represent 2 possi-
bilities: 1) a sedentary position and lack of movement,  
and 2) the inability to move due to hypokinesia.  In the 
present study,  we assessed the approximate changes 
in gait cycle during hypokinesia.  The results showed 
2 opposite changes: ʻFast stepping during hypokinesiaʼ 
and ʻSlow stepping during hypokinesiaʼ.  In our previous 
report [8],  we measured changes in gait cycle during 
24h and showed changes toward a faster rhythm 
mainly in patients who walked with short-stepping,  
festination or freezing of gait (FOG) [8].  Each gait 
parameter could cause shortening of the gait cycle.  
Patients walking with a short stride compensate by 
increasing cadence,  resulting in a fast gait rhythm 
[9-11].  Furthermore,  festination was characterized 
by the gradual shortening of one gait cycle,  whereas 
FOG was deﬁned as an abrupt decrease in the gait 
cycle [8].  On the other hand,  our data also showed a 
shift to a slower rhythm in patients with marked bra-
dykinesia and instability [8].  Prolongation of the 
stepping cycle was due to 2 main deﬁcits: 1) marked 
slowness in the swinging of the lower extremities,  and 
2) protective walking to compensate for marked insta-
bility.  Taken together with previous ﬁndings,  the 
present results indicate that gait bradykinesia is not 
uniform.  Two types of direct disorders that can 
change automatic movement cycles in an opposite man-
ner appear to occur during hypokinesia in PD.
　 Defective production of ﬂoor reaction forces.
It has been postulated that PD patients can only exe-
cute movements of diﬀerent amplitudes at a single,  
slow,  velocity and cannot increase their movement 
velocity [15].  The peak EMG activity that can be 
generated in a muscle burst is limited in PD patients 
[16].  We previously reported decreases in the recip-
rocal muscle activities of the tibialis anterior and 
gastrocnemius muscles in PD patients [7].  Consistent 
with these observations,  the present results showed 
that the range of gait acceleration,  i.e.,  the range of 
ﬂoor reaction forces,  was narrow.  Under these condi-
tions,  PD patients were obliged to produce a particu-
lar degree of force and,  consequently,  disturbance in 
their ability to change force production.  This change 
seems to be the mechanism underlying the monotonous 
impression of walking seen in PD patients.
　 Classiﬁcation of gait disorders: rhythm or 
force? Disordered gait cycle and the ﬂoor reaction 
force appear to be the main pathomechanisms of the 
parkinsonian gait,  since animal experiments showed 
that loss of output from the basal ganglia elicits 
changes in the cycle and muscle activities [17].  In 
these studies,  manipulation by electrical stimuli resulted 
in a slower gait cycle and weaker muscle activity.  
Therefore,  there is a need for a method that can 
quantitatively estimate changes in the gait cycle and 
ﬂoor reaction force to determine the nature of parkin-
sonian gait disorder.  In the present study,  we were 
able to classify our patients into 3 groups based on the 
type of disturbance in gait parameters: the mild gait 
disorder group comprised of patients who walked with 
a normal rhythm and force,  the moderate gait disorder 
group comprised of patients who walked with a slow or 
fast rhythm or with reduced forces,  and the severe gait 
disorder group comprised of patients who walked with 
both an abnormal rhythm and reduced force.  The 
present classiﬁcation correlated with the extent of 
decrease in the amount of overall movements per 24-h.  
For UPDRS-III 26-31 (gait and posture items),  the 
score tended to be higher in the severe group.
　 The present study included patients with mild 
posture disorders,  since they could walk unaided 
throughout the day.  In these patients,  the UPDRS 
gait and posture items were mildly aﬀected.  The nar-
row distribution might explain the lack of signiﬁcant 
diﬀerence in the score of UPDRS 26-31.  The same 
sampling bias in the PGR testing is also applicable to 
a few numbers of patients in the severe gait disorder 
group.
　 Compensatory parkinsonian walking. Our 
results showed no signiﬁcant diﬀerence between the 
mild and moderate gait disorder groups.  One possible 
explanation for this could be compensatory adjust-
ments that can maintain gait performance when only 
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one gait parameter,  e.g.,  cycle or force,  is aﬀected.  
This argument is based on the ﬁnding of compensatory 
eﬀorts commonly seen in patients with various gait 
disorders during walking [7,  18].  Thus,  PD patients 
could improve gait performance by reinforcement of 
the intact gait control mechanisms,  which results in 
preserved activities.  In agreement with this notion,  
previous studies reported that patients with a short 
stride due to decreased kick-oﬀ forces tried to 
increase their cadence (steps/min) by shortening the 
gait cycle [9-11].  Under these conditions,  the 
UPDRS-III gait and posture parameters or the amount 
of overall movements per 24-h would not be severely 
disturbed in patients with the moderate gait disorder 
compared to those with the mild gait disorder.  Taken 
together,  the present results suggest that latent motor 
disturbances could be unexpectedly advanced even in 
patients with mild impairment of various parameters 
of the UPDRS-III gait and posture.  The present clas-
siﬁcation using PGR could be helpful in the early 
detection of such latent gait disorders.
　 In conclusion,  continuous recording of daily lives 
using our newly developed PGR seems to allow the 
detection of elementary and primary deﬁcits in gait 
motor control.  Therefore,  assessment of changes in 
both the gait cycle and gait acceleration could be 
employed to quantitatively deﬁne the severity of gait 
bradykinesia,  and hopefully be used for ﬁne tuning 
dopaminergic medications.
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